No Data
Express News | Kyverna Therapeutics Strengthens Leadership Team to Accelerate Next Phase of Growth
Press Release: Kyverna Therapeutics Strengthens Leadership Team to Accelerate Next Phase of Growth
We Think Kyverna Therapeutics (NASDAQ:KYTX) Can Afford To Drive Business Growth
H.C. Wainwright Maintains Kyverna Therapeutics(KYTX.US) With Hold Rating, Cuts Target Price to $6
Analysts Offer Insights on NA Companies: Viking Holdings Ltd (VIK), Kyverna Therapeutics, Inc. (KYTX) and Amer Sports, Inc. (AS)
Institutional Investors of Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Must Be Disappointed After Last Week's 18% Drop